Posting of Annual Report and Notice of AGM
Nuformix plc has announced the posting of its Annual Financial Report for the year ended 30 September 2025 and the Notice of the 2026 Annual General Meeting to shareholders. The company, which focuses on drug repurposing for fibrosis and oncology, has made the full PDF versions of these documents available on its website. The Annual General Meeting is scheduled to take place on 3 March 2026 at 9:30 a.m. at Arch Law, level 2, Huckletree, 8 Bishopsgate, London, EC2N 4BQ.
Select text to share a quote on X · sign in to keep highlights & notes in your NFX notes
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that the Annual Financial Report for the year ended 30 September 2025 (the "Annual Financial Report 2025") and the 2026 Notice of AGM are today being posted to its shareholders.
A full pdf version of the Annual Financial Report 2025 together with the Notice of AGM is available for download from the Investor Information section on the Company's website: www.nuformix.com.
The Annual General Meeting will be held at the offices of Arch Law, level 2, Huckletree, 8 Bishopsgate, London, EC2N 4BQ at 9.30 a.m. on 3 March 2026.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.